VERISMO THERAPEUTICS
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer. Verismo’s cellular therapy, known as KIR-CAR, is designed to provide a “natural stimulation” to T cells without triggering the T-cell exhaustion for the treatment of solid tumors. The lead therapy candidates in preclinical development are targeting pancreatic cancer, mesothelioma, and ovarian cancer.
VERISMO THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2020-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.verismotherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
215-989-4225
Email Addresses:
[email protected]
Total Funding:
40 M USD
Technology used in webpage:
Euro GoDaddy
Similar Organizations
Amber Therapeutics
Amber Therapeutics develops the next-generation of bioelectrical therapies.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Catalym
Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
Clarapath
We are a medical robotics company developing the SectionStar, a platform to mimic the human histotechnician.
Eyebiotech
Eyebiotech is a privately held ophthalmology biotechnology company.
Headspace Health
Headspace is a digital health platform that provides guided meditation sessions and mindfulness training.
JOGO Health
JOGO Health is a biotech company focused on digital therepeutics for neuromuscular conditions.
Q Bio
On a mission to build the first Clinical Digital Twin Platform and make it accessible to everyone
Rona Therapeutics
Rona Therapeutics is a RNA therapeutics platform enabling discovery and development of modular and programmable RNA medicines.
Current Employees Featured
Founder
Investors List
DongKoo Bio&Pharma
DongKoo Bio&Pharma investment in Seed Round - Verismo Therapeutics
Hong Leong Bank
Hong Leong Bank investment in Seed Round - Verismo Therapeutics
BRV Capital Management
BRV Capital Management investment in Seed Round - Verismo Therapeutics
Key Employee Changes
Official Site Inspections
http://www.verismotherapeutics.com Semrush global rank: 13.24 M Semrush visits lastest month: 78
- Host name: 245.105.62.166.host.secureserver.net
- IP address: 166.62.105.245
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260

More informations about "Verismo Therapeutics"
Verismo Therapeutics - Crunchbase Company Profile
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer. Verismo’s cellular therapy, known as KIR-CAR, is designed to provide a “natural stimulation” to T …See details»
verismotherapeutics.com Reviews: Is this site a scam or legit?
While some are self-explanatory concerning verismotherapeutics.com, let's dive deeper into the remaining ones. Proximity to Potentially Harmful Websites. This metric gauges the connection, …See details»
Verismo Therapeutics Company Profile | Management and
Company Name. Verismo Therapeutics. Main Industry. Research & Development, Business Services. Website. www.verismotherapeutics.comSee details»
Verismo Therapeutics - LinkedIn
Verismo Therapeutics, a clinical-stage biotechnology company developing the novel KIR-CAR platform for solid tumors and blood cancers, today announced a strategic investment from IFLI …See details»
VERISMO THERAPEUTICS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for VERISMO THERAPEUTICS, INC. of Philadelphia, PA. Get the latest business insights from Dun & …See details»
Verismo Therapeutics - PitchBook
Verismo Therapeutics General Information Description. Developer of cancer therapeutics designed to improve persistence and efficacy against solid tumor models. The company …See details»
Verismo Therapeutics Company Overview, Contact Details
[email protected]: 50%. [email protected]: [email protected]: 50%. See more formats. Frequently Asked Questions …See details»
Verismo Therapeutics - Overview, News & Similar companies
Verismo Therapeutics contact info: Phone number: (215) 989-4225 Website: www.verismotherapeutics.com What does Verismo Therapeutics do? Verismo Therapeutics is …See details»
Verismo Therapeutics - Craft
Verismo Therapeutics is a company that develops a KIR-CAR platform for cancer treatment. Its technology is based on chimeric antigen receptors (CAR) T-cell therapy for solid tumors …See details»
Verismo Therapeutics - Contacts, Employees, Board Members, …
Verismo Therapeutics is a biotechnology company that develops CAR T cell therapy for the treatment of solid tumors.See details»
Verismo Therapeutics - Products, Competitors, Financials, …
Headquarters Location. 3675 Market Street Suite 200. Philadelphia, Pennsylvania, 19104, United States. 215-989-4225See details»
Verismo Therapeutics CEO and Key Executive Team | Craft.co
Verismo Therapeutics's Co-Founder and CEO/President is Bryan Kim. Other executives include Raymond Luke, Director of MSAT; Laura A Johnson, Chief Scientific Officer and 3 others. See …See details»
Team - Verismo Therapeutics: Defining a New Generation of KIR …
From Kymriah™ to SynKIR™ Verismo was founded by the inventors of Kymriah™, the first-ever FDA-approved CAR T cell therapy. This same team saw an opportunity to overcome the …See details»
Verismo Therapeutics Inc - Company Profile and News
Company profile page for Verismo Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Verismo Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Sep 7, 2023 Explore Verismo Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 27 news, Disease Domain:Neoplasms, Endocrinology and …See details»
Join Us - Verismo
Start Your Career With Verismo. Verismo is transforming the treatment of solid tumors using nature-inspired multichain receptors. If you’re looking for a rewarding career experience fueled …See details»
Verismo Therapeutics - VentureRadar
Similar Companies: GAIA BioMedicine Unknown Privately Held GAIA BioMedicine, Inc., founded in 2015 as a spin-off venture of Kyushu University, is a technology-driven biopharmaceutical …See details»
Verismo Therapeutics Completes Merger to Accelerate Clinical …
Dec 20, 2024 For more information, visit: www.verismotherapeutics.com. About HLB Group. The HLB Group is comprised of HLB Inc. (KOSDAQ:028300) and its affiliates with a diverse …See details»
Verismo Therapeutics Announces $7 Million Pre-Series A with BRV …
Feb 28, 2023 Lead investor BRV Capital Management is joined by Ignite Innovation. PHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-stage CAR T …See details»
Verismo doses first subject in Phase I trial of SynKIR-310
4 hours ago Subjects will be divided into two cohorts, with each cohort consisting of three to six individuals. Credit: Volha_R/Shutterstock. Verismo Therapeutics has commenced the first …See details»